]>
IRCT20160530028182N6 IRCT 2019-05-15 Sanandaj University of Medical Sciences Aripiprazle in ADHD and ODD The effect of betahistine on hyperactivity disorder in children 2018-05-22 anticipated 76 Complete https://irct.ir/trial/35933 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Individual based-simple randomization, Blinding description: The drug is prepared by the pharmacist and in coding packages which only the pharmacist is aware of its coding and deliverd by researcher to the patient. Neither the investigator, nor the patient nor the analyst, knows the contents of the drug packages and the way they are coded. 3 Attention deficit/hyperactivity disorder. Intervention 1: Intervention group: the research consisted of 76 participants who were randomly assigned to receive intervention and control group. Ritalin 10 mg for the first week of the week (one half a tablet at 8:00 and half a tablet at 14), from the second weekly 2 tablets (one morning) At 8 o'clock, one o'clock 14) and in the case of a weight of over 30 kilograms, from the second week, 3 tablets (one and a half hours at 8 o'clock, one and half hours at 14 o'clock) are prescribed daily. The dosage is 8 mg per day for the first week of the week (half a tablet at 8:00 and half a tablet at 14) and from the second week, 2 tablets (one morning at 8, one hour at 14). Intervention 2: Control group: Ritalin 10 mg for the first week of the week (one half a tablet at 8:00 and half a tablet at 14), from the second weekly 2 tablets (one morning) At 8 o'clock, one o'clock 14) and in the case of a weight of over 30 kilograms, from the second week, 3 tablets (one and a half hours at 8 o'clock, one and half hours at 14 o'clock) are prescribed daily. herapeutic dosage of placebo is prescribed a tablet daily for the first week ( one cap in the morning at 8 o'clock) and 2 cap are daily prescribed in the second week (one cap in the morning at 8 o'clock, one cap at 16 o'clock). Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information available
public Soleiman Mohammadzadeh
Pasdaran street Sanandaj
Sanandaj Iran (Islamic Republic of) 66614713446 +98 87 3366 4653 dr.mohammadzadeh86@muk.ir Sanandaj University of Medical Sciences scientific Dr. Soleiman Mohammadzadeh
Pasdaran street
sanandaj Iran (Islamic Republic of) 66614713446 +98 87 3366 4653 dr.mohammadzadeh86@muk.ac.ir Sanandaj University of Medical Sciences Iran (Islamic Republic of) Age between 8-18 years Diagnosis of ADHD and ODD based on DSM5 without effective medication Taking on mental status at least 2 weeks before the study 8 years 18 years Both Intelectual disability based on clinical suspicious Presence of uncontroled siezure Drug side effects and hypersensivity Recieving of any other drugs History of psychological disorder except for ADHD and ODD Presence of medical diseases such as cardiac diseases F90 Attention deficit/hyperactivity disorder Treatment - Drugs Placebo Intervention group: the research consisted of 76 participants who were randomly assigned to receive intervention and control group. Ritalin 10 mg for the first week of the week (one half a tablet at 8:00 and half a tablet at 14), from the second weekly 2 tablets (one morning) At 8 o'clock, one o'clock 14) and in the case of a weight of over 30 kilograms, from the second week, 3 tablets (one and a half hours at 8 o'clock, one and half hours at 14 o'clock) are prescribed daily. The dosage is 8 mg per day for the first week of the week (half a tablet at 8:00 and half a tablet at 14) and from the second week, 2 tablets (one morning at 8, one hour at 14) Control group: Ritalin 10 mg for the first week of the week (one half a tablet at 8:00 and half a tablet at 14), from the second weekly 2 tablets (one morning) At 8 o'clock, one o'clock 14) and in the case of a weight of over 30 kilograms, from the second week, 3 tablets (one and a half hours at 8 o'clock, one and half hours at 14 o'clock) are prescribed daily. herapeutic dosage of placebo is prescribed a tablet daily for the first week ( one cap in the morning at 8 o'clock) and 2 cap are daily prescribed in the second week (one cap in the morning at 8 o'clock, one cap at 16 o'clock). Improvment in Attention-deficit symptoms. Timepoint: Baselin, second, fourth and eighth weeks after intervention. Method of measurement: Canner's and ADHD Rating scales. Severity of ADHD symptoms. Timepoint: Baselin, second, fourth and eighth weeks after intervention. Method of measurement: ADHD Rating scale and CGI. Sanandaj University of Medical Sciences Approved 2016-08-13 Kurdestan University of Medical Sciences Pasdaran street Sanandaj ُSanandaj Kurdistan Iran (Islamic Republic of)